Ghent University Academic Bibliography

Journal Article
A1
open access

Dinutuximab beta added to temozolomide-based chemotherapy for children with relapsed and refractory neuroblastoma : results of the ITCC-SIOPEN BEACON Immuno Phase II Trial

Juliet C. Gray, Rebekah Weston, Cormac Owens, Adela Canete, Marion Gambart, Bram De Wilde (UGent) , Karsten Nysom, Natasha van Eijkelenburg, Ruth Ladenstein, Aurora Castellano, et al.

(2026) JOURNAL OF CLINICAL ONCOLOGY. 44(3). p.176-187

Add to list

Journal Article
A1
open access

A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH

Lucas E Matthyssens (UGent) , Jed G. Nuchtern, Cees P. Van De Ven, Hany O. S. Gabra, Kristin Bjornland, Sabine Irtan, Jakob Stenman, Luca Pio, Kate M. Cross, Stefano Avanzini, et al.

(2022) ANNALS OF SURGERY. 275(3). p.E575-E585

Add to list

Neuroblastoma

Christine Chung, Tom Boterberg (UGent) , John Lucas, Joseph Panoff, Dominique Valteau-Couanet, Barbara Hero, Rochelle Bagatell and Christine E. Hill-Kayser

(2021) PEDIATRIC BLOOD & CANCER. 68(suppl. 2).

Add to list

Journal Article
A1
open access

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Angela Bellini, Ulrike Pötschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, et al.

(2021) JOURNAL OF CLINICAL ONCOLOGY. 39(30). p.3377-3390

Add to list

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Lucas Moreno, Giuseppe Barone, Steven G. DuBois, Jan Molenaar, Matthias Fischer, Johannes Schulte, Angelika Eggert, Gudrun Schleiermacher, Franki Speleman (UGent) , Louis Chesler, et al.

(2020) EUROPEAN JOURNAL OF CANCER. 136. p.52-68

Add to list

Journal Article
A1
open access

Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Keith Holmes, Ulrike Pötschger, Andrew D. J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas E Matthyssens (UGent) , et al.

(2020) JOURNAL OF CLINICAL ONCOLOGY. 38(25). p.2902-2916

Add to list

Journal Article
A1
open access

Topotecan-vincristine-doxorubicin in stage 4 high risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC : a SIOPEN study

Loredana Amoroso, Giovanni Erminio, Guy Makin, Andrew DJ Pearson, Penelope Brock, Dominique Valteau-Couanet, Victoria Castel, Marlène Pasquet, Genevieve Laureys (UGent) , Caroline Thomas, et al.

(2018) CANCER RESEARCH AND TREATMENT. 50(1). p.148-155

Add to list

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

Maria V Corrias, Stefano Parodi, Andrei Tchirkov, Tim Lammens (UGent) , Ales Vicha, Claudia Pasqualini, Catarina Träger, Yania Yáñez, Sandro Dallorso, Luigi Varesio, et al.

(2018) PEDIATRIC BLOOD & CANCER. 65(7).

Add to list

Validation of postinduction Curie scores in high-risk neuroblastoma : a Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1

Gregory A Yanik, Marguerite T Parisi, Arlene Naranjo, Helen Nadel, Michael J Gelfand, Julie R Park, Ruth L Ladenstein, Ulrike Poetschger, Ariane Boubaker, Dominique Valteau-Couanet, et al.

(2018) JOURNAL OF NUCLEAR MEDICINE. 59(3). p.502-508

Add to list

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Daniel A Morgenstern, Ulrike Pötschger, Lucas Moreno, Vassilios Papadakis, Cormac Owens, Shifra Ash, Claudia Pasqualini, Roberto Luksch, Alberto Garaventa, Adela Canete, et al.

(2018) PEDIATRIC BLOOD & CANCER. 65(11).

Academic Bibliography

Dinutuximab beta added to temozolomide-based chemotherapy for children with relapsed and refractory neuroblastoma : results of the ITCC-SIOPEN BEACON Immuno Phase II Trial

A novel standard for systematic reporting of neuroblastoma surgery : the International Neuroblastoma Surgical Report Form (INSRF), a joint initiative by the Pediatric Oncological Cooperative Groups SIOPEN, COG and GPOH

Neuroblastoma

Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) high-risk neuroblastoma trial (HR-NBL1)

Accelerating drug development for neuroblastoma : summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma

Influence of surgical excision on the survival of patients with stage 4 high-risk neuroblastoma : a report from the HR-NBL1/SIOPEN study

Topotecan-vincristine-doxorubicin in stage 4 high risk neuroblastoma patients failing to achieve a complete metastatic response to rapid COJEC : a SIOPEN study

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

Validation of postinduction Curie scores in high-risk neuroblastoma : a Children's Oncology Group (COG) and SIOPEN group report on SIOPEN/HR-NBL1

Risk stratification of high-risk metastatic neuroblastoma : a report from the HR-NBL-1/SIOPEN study

Contents

Support

Contact